TickerFactsScreenerDevelopers

Contineum Therapeutics, Inc. (CTNM) — Operating Income

Annual figures by fiscal year, from SEC filings.

2023: $16.08M2024: -$50.89M2025: -$68.06M-$68.06M
2023Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$68.06M-33.7%
2024-$50.89M-416.6%
2023$16.08M—